Autobio Diagnostics Co

Autobio Diagnostics Co CROIC

The Cash Return on Invested Capital (CROIC) of Autobio Diagnostics Co (603658.SS) as of Oct 20, 2026 is 8.26 %. In the previous year, Cash Return on Invested Capital (CROIC) was 7.27 % — a change of 13.62% (higher).

CROIC

8.26 %

YoY

13.62%

Last updated:

Cash Return on Invested Capital (CROIC) of Autobio Diagnostics Co is 2025 8.26 % . Cash Return on Invested Capital (CROIC) of Autobio Diagnostics Co was 2024 7.27 % . It decreases by 13.62% higher compared to the previous year.

The Autobio Diagnostics Co CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
12.02 CNY
Jan 1, 2019
2.41 CNY
Jan 1, 2020
-1.81 CNY
Jan 1, 2021
5.26 CNY
Jan 1, 2022
7.83 CNY
Jan 1, 2023
6.40 CNY
Jan 1, 2024
7.27 CNY
Jan 1, 2025
8.26 CNY
The Autobio Diagnostics Co CROIC history
YEARCROICYoY
8.26 %+13.62%
7.27 %+13.68%
6.40 %-18.36%
7.83 %+48.86%
5.26 %-391.24%
-1.81 %-174.95%
2.41 %-79.95%
12.02 %+672.30%
1.56 %-85.64%
10.85 %+1.72%
10.66 %-26.84%
14.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Autobio Diagnostics Co Stock analysis

What does Autobio Diagnostics Co do? Autobio Diagnostics Co., Ltd. generates revenue through the sale of in vitro diagnostic reagents and instruments, including gnostic products, microbiology detection products, and related devices. The company's immunodiagnostic products consist of microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. Microbiology detection products feature training detection reagents, susceptibility detection reagents, and rapid detection reagents. Device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers, all distributed within domestic markets. The firm targets domestic healthcare providers and laboratories as primary buyers of its diagnostic reagents and instruments. Its core products serve clinical diagnostics needs for infectious disease testing, microbial identification, and immune response analysis. The company's product portfolio emphasizes domestic market distribution, with no mention of international sales channels or export activities. Autobio Diagnostics' revenue streams are derived from the manufacturing and distribution of diagnostic reagents, instruments, and related devices. The company focuses on domestic market penetration through its product range, which includes specialized reagents for microbiology and immunodiagnosis. No additional revenue sources such as service contracts or software licensing are indicated in the business description. Autobio Diagnostics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Autobio Diagnostics Co stock

Cash Return on Invested Capital (CROIC) of Autobio Diagnostics Co is 8.26 % in 2025.

Cash Return on Invested Capital (CROIC) of Autobio Diagnostics Co changed from 7.27 % to 8.26 %, representing a 13.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Autobio Diagnostics Co since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Autobio Diagnostics Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Autobio Diagnostics Co

All Key Metrics — Autobio Diagnostics Co